CoChat

In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix

Open access

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Abstract

Our understanding of the spatiotemporal regulation of cardiogenesis is hindered by the difficulties in modeling this complex organ currently by in vitro models. Here we develop a method to generate heart organoids from mouse embryonic stem cell-derived embryoid bodies. Consecutive morphological changes proceed in a self-organizing manner in the presence of the laminin-entactin (LN/ET) complex and fibroblast growth factor 4 (FGF4), and the resulting in vitro heart organoid possesses atrium- and ventricle-like parts containing cardiac muscle, conducting tissues, smooth muscle and endothelial cells that exhibited myocardial contraction and action potentials. The heart organoids exhibit ultrastructural, histochemical and gene expression characteristics of considerable similarity to those of developmental hearts in vivo. Our results demonstrate that this method not only provides a biomimetic model of the developing heart-like structure with simplified differentiation protocol, but also represents a promising research tool with a broad range of applications, including drug testing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-18031-5

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 In vitro generation of developing heart-like structures. a Experimental scheme to generate heart organoid (HO)s in vitro. EBs derived from ESCs were transferred to gelated LN/ET complex-coated chamber slides with HO medium containing FGF4. IVC in vitro culture. b Three representative beating HOs with multiple chambers generated using the above culture system after culturing for 10−11 days (n = over 39, over six experiments). Scale bar: 100 μm. See also Supplementary Movie 1. c HOs tracking morphological changes over a time course during the culture with Matrigel. HOs were classified into four types according to their morphology (n = 12, two experiments). Chamber formation was hindered in the Matrigel culture. Scale bar: 100 μm. d Effect of FGF10 for HO formation. Twenty-four EBs were cultured with FGF10 instead of FGF4 on LN/ET complex (two experiments). Reduced efficiency (42%, n = 12 for the first experiment, and 25%, n = 12 for the second experiment) of chamber formation compared with the FGF4 condition (88%, n = 8 for the first experiment, and 78%, n = 9 for the second experiment) was shown after culturing for 15 days. Data are presented in a violin plot showing all points. Scale bar: 100 μm.
Fig. 1 In vitro generation of developing heart-like structures. a Experimental scheme to generate heart organoid (HO)s in vitro. EBs derived from ESCs were transferred to gelated LN/ET complex-coated chamber slides with HO medium containing FGF4. IVC in vitro culture. b Three representative beating HOs with multiple chambers generated using the above culture system after culturing for 10−11 days (n = over 39, over six experiments). Scale bar: 100 μm. See also Supplementary Movie 1. c HOs tracking morphological changes over a time course during the culture with Matrigel. HOs were classified into four types according to their morphology (n = 12, two experiments). Chamber formation was hindered in the Matrigel culture. Scale bar: 100 μm. d Effect of FGF10 for HO formation. Twenty-four EBs were cultured with FGF10 instead of FGF4 on LN/ET complex (two experiments). Reduced efficiency (42%, n = 12 for the first experiment, and 25%, n = 12 for the second experiment) of chamber formation compared with the FGF4 condition (88%, n = 8 for the first experiment, and 78%, n = 9 for the second experiment) was shown after culturing for 15 days. Data are presented in a violin plot showing all points. Scale bar: 100 μm.CC BY · PubMed Central
Fig. 2 General features of heart organoid (HO)s. a Ultrastructural analysis of the HO (insets, left: whole HO, right: a section stained with toluidine blue). Transmission electron microscopy of CM-like ultrastructures containing myofibrils with Z-bands (Z), mitochondria (M), glycogen granules (Gly) in myofibrils, lipid droplet (LD) and desmosomes (D). Scale bar: 400 nm. N nucleus, SM smooth muscle. Over n = 5, over three experiments. b Transmission electron microscopy of honeycomb sarcoplasmic reticulum (SR) structure (left) and wavy intercalated disc (ID; right) in ultrathin sections of CMs in the HOs. RER ribosomal endoplasmic reticulum, G Golgi complex. Scale bar: 500 nm; over n = 4, over three experiments. c Immunostaining to detect Tbx5 (green) and MHC (pink) (over n = 7, two experiments). The HO at day 11 and at day 15 (left panel, bright field, scale bar: 100 μm). Inset indicates hematoxylin and eosin-staining. Tbx5 expression (green) was positive in the left atrium (LA)-, right atrium (RA)- and left ventricle (LV)-like parts, MHC expression (pink) was strongly expressed in both LV- and RV-like parts, and a Tbx5-positive atria/ventricle (A/V) cushion-like structure was also detected (arrow). DAPI (blue) for nuclear staining.
Fig. 2 General features of heart organoid (HO)s. a Ultrastructural analysis of the HO (insets, left: whole HO, right: a section stained with toluidine blue). Transmission electron microscopy of CM-like ultrastructures containing myofibrils with Z-bands (Z), mitochondria (M), glycogen granules (Gly) in myofibrils, lipid droplet (LD) and desmosomes (D). Scale bar: 400 nm. N nucleus, SM smooth muscle. Over n = 5, over three experiments. b Transmission electron microscopy of honeycomb sarcoplasmic reticulum (SR) structure (left) and wavy intercalated disc (ID; right) in ultrathin sections of CMs in the HOs. RER ribosomal endoplasmic reticulum, G Golgi complex. Scale bar: 500 nm; over n = 4, over three experiments. c Immunostaining to detect Tbx5 (green) and MHC (pink) (over n = 7, two experiments). The HO at day 11 and at day 15 (left panel, bright field, scale bar: 100 μm). Inset indicates hematoxylin and eosin-staining. Tbx5 expression (green) was positive in the left atrium (LA)-, right atrium (RA)- and left ventricle (LV)-like parts, MHC expression (pink) was strongly expressed in both LV- and RV-like parts, and a Tbx5-positive atria/ventricle (A/V) cushion-like structure was also detected (arrow). DAPI (blue) for nuclear staining.CC BY · PubMed Central
Fig. 3 Different morphological stages during the in vitro cardiogenesis. a Heart organoid (HO) tracking over a time course (over n = 84, over six independent experiments). The cardiac-crescent-like structures (CCL, top) or sphere with buds (Sb; similar to a small heart tube with polarity, bottom) appeared within 3 days of culture. Arrows indicate buds in a Sb. These structures underwent continuous morphological changes into heart tubes (HT), looping heart tubes (LHT) and chambered hearts (scale bar: 100 µm). The HOs were classified as being in the cardiac-crescent-like, Sb, heart tube, looping heart tube, or chamber-formation (CF) stage. b Half of the cultured HOs showed spontaneous beating movement within 3 days of culture (57.6%). The number of beating HOs increased at day 6 (75.4%; n = 84, six independent experiments). See also Supplementary Movie 4. c Morphological changes in the EBs appeared within 3 days of culture. At day 3, EBs with a spherical shape prior to culture had transformed into cardiac-crescent-like structures or Sbs (92.0%). Most EBs showed morphological changes until day 6 (97.3%). d Frequency of HOs with certain morphological characteristics according to the culture period. The majority of the HOs were classified as being in the cardiac-crescent-like stage (red bar) at day 3 and transformed to the heart tube and looping heart tube stages (light green and purple, respectively, days 5−6), looping heart tube and chamber-formation stages (purple and black, respectively, day 9) and finally to the chamber-formation stage (black) at days 10−15. Data are presented as mean values ± SEM in (b–d).
Fig. 3 Different morphological stages during the in vitro cardiogenesis. a Heart organoid (HO) tracking over a time course (over n = 84, over six independent experiments). The cardiac-crescent-like structures (CCL, top) or sphere with buds (Sb; similar to a small heart tube with polarity, bottom) appeared within 3 days of culture. Arrows indicate buds in a Sb. These structures underwent continuous morphological changes into heart tubes (HT), looping heart tubes (LHT) and chambered hearts (scale bar: 100 µm). The HOs were classified as being in the cardiac-crescent-like, Sb, heart tube, looping heart tube, or chamber-formation (CF) stage. b Half of the cultured HOs showed spontaneous beating movement within 3 days of culture (57.6%). The number of beating HOs increased at day 6 (75.4%; n = 84, six independent experiments). See also Supplementary Movie 4. c Morphological changes in the EBs appeared within 3 days of culture. At day 3, EBs with a spherical shape prior to culture had transformed into cardiac-crescent-like structures or Sbs (92.0%). Most EBs showed morphological changes until day 6 (97.3%). d Frequency of HOs with certain morphological characteristics according to the culture period. The majority of the HOs were classified as being in the cardiac-crescent-like stage (red bar) at day 3 and transformed to the heart tube and looping heart tube stages (light green and purple, respectively, days 5−6), looping heart tube and chamber-formation stages (purple and black, respectively, day 9) and finally to the chamber-formation stage (black) at days 10−15. Data are presented as mean values ± SEM in (b–d).CC BY · PubMed Central
Fig. 4 Expressions of cardiac transcription factors (TFs) and its perturbation in heart organoid (HO)s. a Immunofluorescent staining to detect Nkx2-5 (green) and Tbx5 (red) in cardiac-crescent-like structures at day 3 of HO culture (n = 8, two experiments). Scale bar: 100 μm. b Immunofluorescent staining to detect Nkx2-5 (green) and Tbx5 (red) in HOs was cultured for more than 9 days. The representative HO (n = 13 out of n = 16) showed expression similar to that in embryonic hearts (E11.5). Scale bar: 100 μm. c, d Recapitulation of cardiac perturbation during in vitro HO formation from Tbx5 KO- and Isl1 KO-ESCs. c Immunofluorescent staining to detect Nkx2-5 (green) and Tbx5 (red) at day 3 of HO culture from derived Tbx5 KO- (n = 17, left) and Isl1 KO-ESCs (n = 16, right). In the Tbx5 KO-derived HO, delayed or abnormal morphogenesis was observed with decreased Tbx5 expression and disrupted typical location of Tbx5 and Nkx2-5. In the case of Isl1 KO-derived HOs, the expression of Tbx5 and Nkx2-5 was not clearly separated. Two experiments. Scale bar: 100 μm. d Immunofluorescent staining to detect cTnT (a CM marker, green)/αSMA (an SM marker, red) at day 6 of HO culture from derived Tbx5 KO- (n = 16, two experiments), Isl1 KO- (n = 17), and WT-ESCs (n = 9). The weak expressions of cTnT and/or αSMA compared to those of control (WT) HOs at day 6. Scale bar: 100 μm.
Fig. 4 Expressions of cardiac transcription factors (TFs) and its perturbation in heart organoid (HO)s. a Immunofluorescent staining to detect Nkx2-5 (green) and Tbx5 (red) in cardiac-crescent-like structures at day 3 of HO culture (n = 8, two experiments). Scale bar: 100 μm. b Immunofluorescent staining to detect Nkx2-5 (green) and Tbx5 (red) in HOs was cultured for more than 9 days. The representative HO (n = 13 out of n = 16) showed expression similar to that in embryonic hearts (E11.5). Scale bar: 100 μm. c, d Recapitulation of cardiac perturbation during in vitro HO formation from Tbx5 KO- and Isl1 KO-ESCs. c Immunofluorescent staining to detect Nkx2-5 (green) and Tbx5 (red) at day 3 of HO culture from derived Tbx5 KO- (n = 17, left) and Isl1 KO-ESCs (n = 16, right). In the Tbx5 KO-derived HO, delayed or abnormal morphogenesis was observed with decreased Tbx5 expression and disrupted typical location of Tbx5 and Nkx2-5. In the case of Isl1 KO-derived HOs, the expression of Tbx5 and Nkx2-5 was not clearly separated. Two experiments. Scale bar: 100 μm. d Immunofluorescent staining to detect cTnT (a CM marker, green)/αSMA (an SM marker, red) at day 6 of HO culture from derived Tbx5 KO- (n = 16, two experiments), Isl1 KO- (n = 17), and WT-ESCs (n = 9). The weak expressions of cTnT and/or αSMA compared to those of control (WT) HOs at day 6. Scale bar: 100 μm.CC BY · PubMed Central
Fig. 5 Evaluation of the cell components of heart organoid (HO)s. a Immunofluorescent staining to detect cTnT (a CM marker, green)/αSMA (an SM marker, red) and b PECAM (an EC marker, red) in the HO and E10.5 heart cryosections. Expression of cTnT and αSMA was observed in the HOs (n = 7 out of n = 9, two experiments). Also, segregated lining expression of PECAM (red) was detected in the HOs (over n = 9, two experiments). Scale bar: 100 μm. c–f Immunostaining to detect c GATA4 (red)/cTnT (green), d Cx43 (red)/Cx40 (green), e Cx43 (red)/Cx45 (green), and f AFP (red)/cTnT (green). Scale bar: 50 μm. c Expression of GATA4, a cardiac TF, was observed in both HOs (n = 8 out of n = 9, two experiments) and E12.5 heart. d Expression of Cx40 in atrium-like region detected in the HOs (n = 7 out of n = 13, two experiments) was similar to that of atrium in E13.5 heart. e The organized distribution of two types of Connexin (Cx43 and Cx45) in the HOs (over n = 8, two experiments) was similar to that of E12.5 heart (the ventricle part), although a small number of Cx45 (green)-positive cells was observed. f No expression of AFP (a liver marker) was detected in both HOs (n = 8, over two biologically independent experiments) and E12.5 heart.
Fig. 5 Evaluation of the cell components of heart organoid (HO)s. a Immunofluorescent staining to detect cTnT (a CM marker, green)/αSMA (an SM marker, red) and b PECAM (an EC marker, red) in the HO and E10.5 heart cryosections. Expression of cTnT and αSMA was observed in the HOs (n = 7 out of n = 9, two experiments). Also, segregated lining expression of PECAM (red) was detected in the HOs (over n = 9, two experiments). Scale bar: 100 μm. c–f Immunostaining to detect c GATA4 (red)/cTnT (green), d Cx43 (red)/Cx40 (green), e Cx43 (red)/Cx45 (green), and f AFP (red)/cTnT (green). Scale bar: 50 μm. c Expression of GATA4, a cardiac TF, was observed in both HOs (n = 8 out of n = 9, two experiments) and E12.5 heart. d Expression of Cx40 in atrium-like region detected in the HOs (n = 7 out of n = 13, two experiments) was similar to that of atrium in E13.5 heart. e The organized distribution of two types of Connexin (Cx43 and Cx45) in the HOs (over n = 8, two experiments) was similar to that of E12.5 heart (the ventricle part), although a small number of Cx45 (green)-positive cells was observed. f No expression of AFP (a liver marker) was detected in both HOs (n = 8, over two biologically independent experiments) and E12.5 heart.CC BY · PubMed Central
Fig. 6 Purkinje cells and T-tubule-associated components in heart organoid (HO)s. a Immunostaining to detect TRPM4 (red), a Purkinje cell marker, and cTnT (green) in HOs (left panels, n = 14, two independent experiments) and in E9.5 and E10.5 hearts (right panels). Scale bar: 100 μm. b Purkinje-specific myocytes in the HOs (over n = 3, over two experiments). A wide Z band, abundant intermediate filaments, and/or sparse myofibrils were observed (left panels). Both Purkinje cells (M bands (arrows) and wide Z bands) and working (ordinary) myocytes in the HOs were observed together in cell-to-cell contact, showing the protrusion of Purkinje cells (white dotted circle) into working myocytes (right panels). Scale bar: 400 nm. c RYR2 immunostaining in the HOs (left and middle panel, n = 13, three biologically independent experiments) and an E12.5 heart (right). Inset indicates an entire section of the HO. Scale bar: 100 μm.
Fig. 6 Purkinje cells and T-tubule-associated components in heart organoid (HO)s. a Immunostaining to detect TRPM4 (red), a Purkinje cell marker, and cTnT (green) in HOs (left panels, n = 14, two independent experiments) and in E9.5 and E10.5 hearts (right panels). Scale bar: 100 μm. b Purkinje-specific myocytes in the HOs (over n = 3, over two experiments). A wide Z band, abundant intermediate filaments, and/or sparse myofibrils were observed (left panels). Both Purkinje cells (M bands (arrows) and wide Z bands) and working (ordinary) myocytes in the HOs were observed together in cell-to-cell contact, showing the protrusion of Purkinje cells (white dotted circle) into working myocytes (right panels). Scale bar: 400 nm. c RYR2 immunostaining in the HOs (left and middle panel, n = 13, three biologically independent experiments) and an E12.5 heart (right). Inset indicates an entire section of the HO. Scale bar: 100 μm.CC BY · PubMed Central
Fig. 7 Global gene expression in heart organoid (HO)s. a Principle component analysis of gene expression in HOs cultured for 9 days (n = 3) and for 13 days (n = 3), and in EBs (n = 3), E9.5 hearts (n = 2), and E11.5 hearts (n = 3). The HOs are located near the hearts. Hemoglobin complex-related genes, including Hbb-y, Hba-x, and Hbb-bh, were excluded from the PCA analysis. b Heat map and hierarchical clustering analyses based on the differentially expressed genes between the in vivo embryonic hearts (E9.5 and E11.5) and the EBs without further culturing. Hbb-y, Hba-x, and Hbb-bh are indicated with asterisks. c Gene expression profiles of representative genes for (i) atrium/ventricle regional markers, (ii) markers during embryonic heart development, (iii) general stem cell markers, (iv) CM markers and (v) markers for other tissues including Foxa2/Sox17 (liver and intestine), Pdx1 (pancreas), Myod1 (skeletal muscle), and Otx2/Tbr1 (central nervous system). d MA plot showing the differentially expressed genes between the HOs and EBs (the y axis indicates the log intensity ratio, and the x axis indicates the mean average of log intensity). Genes with a log2-fold change > 5 are shown in red (396 genes), and those with a log2-fold change <−5 are shown in blue (55 genes). e GO analysis based on the 396 upregulated genes of (d) (P value = from 2.79E−18 to 3.89E−11; two-sided Wald test, log2-fold change > 5, middle panel) and the 55 downregulated genes of (d) (bottom; P value = from 8.14E−20 to 2.21E−11; two-sided Wald test, log2-fold change < −5, bottom panel). Source data are provided as a source data file.
Fig. 7 Global gene expression in heart organoid (HO)s. a Principle component analysis of gene expression in HOs cultured for 9 days (n = 3) and for 13 days (n = 3), and in EBs (n = 3), E9.5 hearts (n = 2), and E11.5 hearts (n = 3). The HOs are located near the hearts. Hemoglobin complex-related genes, including Hbb-y, Hba-x, and Hbb-bh, were excluded from the PCA analysis. b Heat map and hierarchical clustering analyses based on the differentially expressed genes between the in vivo embryonic hearts (E9.5 and E11.5) and the EBs without further culturing. Hbb-y, Hba-x, and Hbb-bh are indicated with asterisks. c Gene expression profiles of representative genes for (i) atrium/ventricle regional markers, (ii) markers during embryonic heart development, (iii) general stem cell markers, (iv) CM markers and (v) markers for other tissues including Foxa2/Sox17 (liver and intestine), Pdx1 (pancreas), Myod1 (skeletal muscle), and Otx2/Tbr1 (central nervous system). d MA plot showing the differentially expressed genes between the HOs and EBs (the y axis indicates the log intensity ratio, and the x axis indicates the mean average of log intensity). Genes with a log2-fold change > 5 are shown in red (396 genes), and those with a log2-fold change <−5 are shown in blue (55 genes). e GO analysis based on the 396 upregulated genes of (d) (P value = from 2.79E−18 to 3.89E−11; two-sided Wald test, log2-fold change > 5, middle panel) and the 55 downregulated genes of (d) (bottom; P value = from 8.14E−20 to 2.21E−11; two-sided Wald test, log2-fold change < −5, bottom panel). Source data are provided as a source data file.CC BY · PubMed Central
Fig. 8 Formation of atrium- and ventricle-like structures in heart organoid (HO)s. a Immunostaining for Mlc2v (red) and Mlc2a (green) in the HOs (n = 30, over three independent experiments). Left: a whole HO. Middle: high-resolution images of the atrium- and ventricle-like regions corresponding to the insets in left panel. Right: embryonic hearts from E10.5 and E12.5. Scale bar: 50 μm. See also Supplementary Fig. 6a. b Whole-mount immunostaining of Mlc2v (red) and Mlc2a (green) in the HOs. Distinct Mlc2a-positive atrial cells were detected in the HO (over n = 6, over three independent experiments). Scale bar: 50 μm. c The HOs (over n = 3, over two experiments) possessed mainly two parts (top panel; a section stained with toluidine blue) with cells exhibiting features of the atrial myocytes (high density of mitochondria dispersed in cells and secretory vesicles, left) and features of the ventricular myocytes (well-structured sarcomeres with Z band and myofibrils containing glycogens, right). These morphological features are similar to those of the in vivo embryonic hearts. M mitochondria, SV secretory vesicles, G Golgi complex, N nucleus, RER ribosomal endoplasmic reticulum. A (yellow), atrium; V (red), ventricle in the insets. Scale bar: 400 nm. d Gene expression pattern of atrium- and ventricle-like structures in HOs. The HOs cultured for 13 days (n = 3) were surgically dissected to each atrium- and ventricle-like parts for RNA-seq analysis. Specific genes showing the similar chamber expression patterns in HOs and E11.5H. See also Supplementary Fig. 6b. Source data are provided as a source data file. e Ventricular- and atrial-specific gene expression profiles in dissected HOs and E11.5H based on the 951 differentially expressed genes (−1 < log2-fold change > 1, adjusted P value < 0.05) between atria and ventricles of E11.5H.
Fig. 8 Formation of atrium- and ventricle-like structures in heart organoid (HO)s. a Immunostaining for Mlc2v (red) and Mlc2a (green) in the HOs (n = 30, over three independent experiments). Left: a whole HO. Middle: high-resolution images of the atrium- and ventricle-like regions corresponding to the insets in left panel. Right: embryonic hearts from E10.5 and E12.5. Scale bar: 50 μm. See also Supplementary Fig. 6a. b Whole-mount immunostaining of Mlc2v (red) and Mlc2a (green) in the HOs. Distinct Mlc2a-positive atrial cells were detected in the HO (over n = 6, over three independent experiments). Scale bar: 50 μm. c The HOs (over n = 3, over two experiments) possessed mainly two parts (top panel; a section stained with toluidine blue) with cells exhibiting features of the atrial myocytes (high density of mitochondria dispersed in cells and secretory vesicles, left) and features of the ventricular myocytes (well-structured sarcomeres with Z band and myofibrils containing glycogens, right). These morphological features are similar to those of the in vivo embryonic hearts. M mitochondria, SV secretory vesicles, G Golgi complex, N nucleus, RER ribosomal endoplasmic reticulum. A (yellow), atrium; V (red), ventricle in the insets. Scale bar: 400 nm. d Gene expression pattern of atrium- and ventricle-like structures in HOs. The HOs cultured for 13 days (n = 3) were surgically dissected to each atrium- and ventricle-like parts for RNA-seq analysis. Specific genes showing the similar chamber expression patterns in HOs and E11.5H. See also Supplementary Fig. 6b. Source data are provided as a source data file. e Ventricular- and atrial-specific gene expression profiles in dissected HOs and E11.5H based on the 951 differentially expressed genes (−1 < log2-fold change > 1, adjusted P value < 0.05) between atria and ventricles of E11.5H.CC BY · PubMed Central
Fig. 9 Functional maturity of heart organoid (HO)s. a Ca2+ transients in the HOs. Ca2+ oscillations were analyzed using the Ca2+-binding fluorescent dyes Fluo8 AM. Representative images of HOs (n = 7, two experiments, each top left panels, bright field and bottom left panels: fluorescent images). Three fluorescent images were extracted from every ten frames of sequential images (each right column, see also Supplementary Fig. 7). Scale bar: 100 μm. b Ca2+ transients in the 11-day cultured HOs, pre- and post administration of the β adrenergic agonist isoproterenol (1 μM). Beating rate was increased and time constant of Ca2+ decay was decreased after treatment of isoproterenol (left, n = 6, P = 0.0055 and 0.0046 by two-sided paired t test). The representative traces of changed Ca2+ signal (F/F0) before and after the treatment of isoproterenol (right). c IK1 immunostaining in a representative HO (left, n = 10 out of n = 12, two independent experiments), embryonic hearts (E9.5, E10.5 and E12.5; middle) and a postnatal day 1 (P1) mouse heart (right). Inset indicates the whole image of P1 mouse heart. Scale bar: 100 μm (HO), and 1 mm (P1 mouse heart).
Fig. 9 Functional maturity of heart organoid (HO)s. a Ca2+ transients in the HOs. Ca2+ oscillations were analyzed using the Ca2+-binding fluorescent dyes Fluo8 AM. Representative images of HOs (n = 7, two experiments, each top left panels, bright field and bottom left panels: fluorescent images). Three fluorescent images were extracted from every ten frames of sequential images (each right column, see also Supplementary Fig. 7). Scale bar: 100 μm. b Ca2+ transients in the 11-day cultured HOs, pre- and post administration of the β adrenergic agonist isoproterenol (1 μM). Beating rate was increased and time constant of Ca2+ decay was decreased after treatment of isoproterenol (left, n = 6, P = 0.0055 and 0.0046 by two-sided paired t test). The representative traces of changed Ca2+ signal (F/F0) before and after the treatment of isoproterenol (right). c IK1 immunostaining in a representative HO (left, n = 10 out of n = 12, two independent experiments), embryonic hearts (E9.5, E10.5 and E12.5; middle) and a postnatal day 1 (P1) mouse heart (right). Inset indicates the whole image of P1 mouse heart. Scale bar: 100 μm (HO), and 1 mm (P1 mouse heart).CC BY · PubMed Central
Fig. 10 Electrophysiological properties of heart organoid (HO)s. a Activation map during spontaneous excitation (left). Each local action potential of atrium-like (black and red) and ventricle-like (blue) components was presented in diagrams (right). b Action potential duration (APD90) in each atrium- and ventricle-like action potential of HOs (n = 6, P = 0.0245 by two-sided paired t test). Data are presented as mean values ± SEM. c APD90 of HOs was analyzed by optical mapping in HOs pre- and post treatment with 100 nM of E4031 (left, n = 6, P = 0.0004 by two-sided paired t test). Data are presented as mean values ± SEM. The representative optical mapping data of HOs pre- and post treatment with 100 nM of E4031 (right). d Action potentials recorded by optical mapping in HOs, pre- (top) and post (bottom) treatment with the IKr blocker E4031 (1 μM). High-resolution activation maps (left panels) show that the excitation pattern and excitation propagation speed are different in HOs before and after treatment with E4031 (right diagrams, see also Supplementary Movie 7).
Fig. 10 Electrophysiological properties of heart organoid (HO)s. a Activation map during spontaneous excitation (left). Each local action potential of atrium-like (black and red) and ventricle-like (blue) components was presented in diagrams (right). b Action potential duration (APD90) in each atrium- and ventricle-like action potential of HOs (n = 6, P = 0.0245 by two-sided paired t test). Data are presented as mean values ± SEM. c APD90 of HOs was analyzed by optical mapping in HOs pre- and post treatment with 100 nM of E4031 (left, n = 6, P = 0.0004 by two-sided paired t test). Data are presented as mean values ± SEM. The representative optical mapping data of HOs pre- and post treatment with 100 nM of E4031 (right). d Action potentials recorded by optical mapping in HOs, pre- (top) and post (bottom) treatment with the IKr blocker E4031 (1 μM). High-resolution activation maps (left panels) show that the excitation pattern and excitation propagation speed are different in HOs before and after treatment with E4031 (right diagrams, see also Supplementary Movie 7).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 59 references

Cited by

See all 154

Metadata

Authors
Lee, J., Sutani, A., Kaneko, R., Takeuchi, J., Sasano, T., Kohda, T., Ihara, K., Takahashi, K., Yamazoe, M., Morio, T., Furukawa, T., & Ishino, F.
Affiliations
Tokyo Medical and Dental University (JP)
Corresponding author
  • Lee, Jiyoung
  • Ishino, Fumitoshi
Venue
Nature Communications
Published
2020-09-03
Volume
11
Issue
1
Pages
4283-4283
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3082670483
Cited by
154
References
59
Citations by year
2026: 15 · 2025: 27 · 2024: 25 · 2023: 27 · 2022: 31 · 2021: 28 · 2020: 1
FWCI
7.06
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Tokyo Medical and Dental University
  • Japan Society for the Promotion of Science (19H00978, 19KK0182, 19K08536, 20K06652, 18H02803, 20K21598, 20K20584, 19KK0218)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
heart development, embryonic stem cells, embryoid bodies, FGF4, extracellular matrix, self-organization, cardiac contraction, action potential, drug testing
MeSH terms
Mouse Embryonic Stem Cells, Action Potentials, Amino Acids, Diamino, Animals, Cell Differentiation, Cell Line, Extracellular Matrix, Heart, Membrane Glycoproteins, Myocardial Contraction, Myocardium, Organoids, Biomimetics, Endothelial Cells, Mice, Fibroblast Growth Factor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix. https://app.cochat.ai/papers/10.1038/s41467-020-18031-5
The paper
Lee, J., Sutani, A., Kaneko, R., Takeuchi, J., Sasano, T., Kohda, T., Ihara, K., Takahashi, K., Yamazoe, M., Morio, T., Furukawa, T., & Ishino, F. (2020). In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix. Nature Communications. https://doi.org/10.1038/s41467-020-18031-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.